(Q38151997)

29 August 2017

Dietary n-3 PUFA and CVD: a review of the evidence (English)

1 reference

29 August 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24119287%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Trevor A Mori

series ordinal

1

1 reference

29 August 2017

11 October 2013

1 reference

Proceedings of the Nutrition Society

29 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24119287%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24119287%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24119287%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

57-64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24119287%20AND%20SRC:MED&resulttype=core&format=json

Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

n-3 fatty acids and the risk of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Do long-chain n-3 fatty acids reduce arterial stiffness? A meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Fish oil amplifies the effect of propranolol in mild essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

A trial of omega-3 fatty acids for prevention of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Docosahexaenoic acid but not eicosapentaenoic acid increases LDL particle size in treated hypertensive type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Why do omega-3 fatty acids lower serum triglycerides?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

n-3 fatty acids in patients with multiple cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Fish consumption and risk of stroke and its subtypes: accumulative evidence from a meta-analysis of prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Fish intake and risk of incident heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middle-aged and elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Meta-analysis of observational studies on fish intake and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: Results from two placebo-controlled interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Fish oil supplementation in pregnancy lowers F2-isoprostanes in neonates at high risk of atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Resolvins and protectins in inflammation resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Omega-3 fatty acids and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Polyunsaturated fatty acids, inflammation, and immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Isoprostane generation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

n-3 fatty acids and lipoproteins: comparison of results from human and animal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Marine oils and cardiovascular reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Emerging roles of resolvins in the resolution of inflammation and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Resolution phase lipid mediators of inflammation: agonists of resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Resolution of inflammation: state of the art, definitions and terms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Novel omega -- 3-derived local mediators in anti-inflammation and resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Endogenous receptor agonists: resolving inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

n-3 polyunsaturated fatty acids and coronary thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Fish oil supplementation in type 2 diabetes: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Fish oil and glycemic control in diabetes. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Does fish oil lower blood pressure? A meta-analysis of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Marine n-3 polyunsaturated fatty acids and coronary heart disease: Part II. clinical trials and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part I. Background, epidemiology, animal data, effects on risk factors and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

Fish consumption and incidence of stroke: a meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Dietary fatty acids in human thrombosis and hemostasis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Macrophage death and defective inflammation resolution in atherosclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Fatty acid modulation of endothelial activation

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

A low-sodium diet supplemented with fish oil lowers blood pressure in the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

n-3 fatty acids and serum lipoproteins: human studies

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665113003583

7 January 2021

10.1017/S0029665113003583

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24119287%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference